secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2024-12-26T23:59:59+00:00
Accession:  0001683168-24-008984
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio raises ~$0.48M in registered direct offering of 240K shares at $2.00/share with warrants
--------------------------------------------------------------------------------

- Sold 240,000 shares of common stock at $2.00/share for gross proceeds of ~$0.48M; net ~$0.48M after expenses.
- Issued warrants to purchase up to 240,000 additional shares at $2.00/share, exercisable immediately, expiring in 5 years.
- H.C. Wainwright acted as placement agent; cash fees of 7.5% of gross proceeds plus management fee and warrants.
- Proceeds to be used for working capital and general corporate purposes.
- Closing occurred on Dec 24, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824008984/0001683168-24-008984-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316824008984/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008984

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer